The Experimental Drug Development Centre (EDDC) is at the forefront of advancing Singapore-discovered therapeutic assets from concept to commercialization. We collaborate closely with multidisciplinary teams of scientists to translate cutting-edge research into innovative healthcare solutions.
Responsibilities:
- Evaluate projects entering EDDC’s portfolio by conducting thorough business due diligence.
- Perform market analysis and continuously monitor the competitive landscape as projects progress within our portfolio.
- Foster strong relationships with local and international scientific and business partners crucial to EDDC's success.
- Lead contractual negotiations and participate in commercialization discussions (e.g., out-licensing, co-development) with third parties in collaboration with A* Innovation & Enterprise and A*STAR Legal.
- Represent EDDC and its projects at meetings with external academic and industry partners.
- Attend international industry partnering conferences to connect with potential pharma and biotech partners, showcase EDDC’s drug discovery efforts, and establish strategic partnerships.
- Assist in refining EDDC’s value proposition for drug co-development and venture creation with local and international entities.
Requirements:
- Degree in biology, biochemistry, or related discipline. With additional qualifications in business administration, finance, or a related field will be a plus. Advanced degree (e.g., MBA, PhD) preferred.
- Proven experience in business development within the pharmaceutical or biotechnology industry, including deal-making and strategic partnerships.
- Strong understanding of drug development processes, market dynamics, and intellectual property considerations.
- Excellent communication, negotiation, and interpersonal skills, with the ability to engage effectively with diverse stakeholders.
- Ability to thrive in a dynamic, collaborative environment and manage multiple projects concurrently.
- Experience managing due diligence (including the use of virtual datarooms) and licensing negotiations will be a plus.
